Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has assisted Peab in connection with a transaction with SkiStar
Mandate

Vinge has assisted Peab in connection with a transaction with SkiStar

May 28, 2021 Capital Markets and Public M&A Real Estate and Construction

Vinge has assisted Peab in connection with a transaction with Skistar, whereby Peab and SkiStar deepen the collaboration on management and development of properties in the Scandinavian mountains.

Through the transaction, three jointly owned lodges in the Swedish and Norwegian mountainside locations are transferred to the same group structure and in addition, the joint ventures will acquire three new lodges in Hemsedal in Norway, Lindvallen in Sälen and Hundfjället in Sälen (under construction) and development rights for around 60,000 GFA in Sälen, Vemdalen, Åre and Duved. In addition, in connection with the transaction, SkiStar is to sign new leases on both the newly acquired properties and the previously jointly owned properties.

Vinge’s team consisted of Charlotte Levin, Assur Badur, Kristoffer Larson and Joel Magnusson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025